Description
Using complementarity-determining region (CDR) grafting technology and computer-aided molecular modeling, Sino Biological provides high-quality monoclonal antibody humanization services that enable a high degree of successful humanization (>95%).
Service Highlights:
• 100% success rate
• The sequence homology is greater than 95%; PTM and aggregation prediction report are also available.
• As fast as 3-4 weeks to deliver desired humanized antibodies
• Affinity validated by ELISA and SPR/BLI